Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
Journal of Cancer Research and Clinical Oncology
|
July 28, 2020
Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer
Thomas Walter, Neil S Hawkins, Richard F Pollock, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
November 11, 2024
Cost-Utility of Real-Time Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Spain
Juan Francisco Merino-Torres, Sabrina Ilham, Hamza Alshannaq, et al.
Advances in Therapy
|
November 1, 2022
Advances in Delivery of Selective Internal Radiation Therapy (SIRT): Economic and Logistical Effects of Same-Stay Work-Up and Procedure in the Treatment of Unresectable Liver Tumors in England
Richard F Pollock, Suki Shergill, Phuong Lien Carion, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 1, 2025
Cost-Utility of Real-Time Continuous Glucose Monitoring Versus Self-monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Sweden
Johan Jendle, Sabrina Ilham, Hamza Alshannaq, et al.
Frontiers in Oncology
|
April 4, 2024
High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma
Johannes Pöhlmann, Michael Weller, Andrea Marcellusi, et al.
Journal of Comparative Effectiveness Research
|
January 31, 2024
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France
Hamza Alshannaq, Richard F Pollock, Michael Joubert, et al.
Diabetes, Obesity & Metabolism
|
June 19, 2023
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark
Hamza Alshannaq, Greg Cogswell, Richard F Pollock, et al.
Journal of Diabetes Investigation
|
April 1, 2026
Cost-effectiveness analysis comparing real-time continuous glucose monitoring with self-monitoring of blood glucose for patients with type 2 diabetes treated with insulin in Japan
Hirotaka Watada, Shiro Tanaka, Jessica Y Matuoka, et al.
Advances in Therapy
|
December 5, 2025
Evaluating the Cost-Effectiveness of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in the Treatment of Patients with Insulin-Treated Type 2 Diabetes in Australia
Hamza Alshannaq, David Simmons, Jessica Y Matuoka, et al.
Journal of Comparative Effectiveness Research
|
September 5, 2023
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada
Hamza Alshannaq, John J Isitt, Richard F Pollock, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
Journal of Cancer Research and Clinical Oncology
|
July 28, 2020
Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer
Thomas Walter, Neil S Hawkins, Richard F Pollock, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
November 11, 2024
Cost-Utility of Real-Time Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Spain
Juan Francisco Merino-Torres, Sabrina Ilham, Hamza Alshannaq, et al.
Advances in Therapy
|
November 1, 2022
Advances in Delivery of Selective Internal Radiation Therapy (SIRT): Economic and Logistical Effects of Same-Stay Work-Up and Procedure in the Treatment of Unresectable Liver Tumors in England
Richard F Pollock, Suki Shergill, Phuong Lien Carion, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 1, 2025
Cost-Utility of Real-Time Continuous Glucose Monitoring Versus Self-monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Sweden
Johan Jendle, Sabrina Ilham, Hamza Alshannaq, et al.
Frontiers in Oncology
|
April 4, 2024
High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma
Johannes Pöhlmann, Michael Weller, Andrea Marcellusi, et al.
Journal of Comparative Effectiveness Research
|
January 31, 2024
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France
Hamza Alshannaq, Richard F Pollock, Michael Joubert, et al.
Diabetes, Obesity & Metabolism
|
June 19, 2023
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark
Hamza Alshannaq, Greg Cogswell, Richard F Pollock, et al.
Journal of Diabetes Investigation
|
April 1, 2026
Cost-effectiveness analysis comparing real-time continuous glucose monitoring with self-monitoring of blood glucose for patients with type 2 diabetes treated with insulin in Japan
Hirotaka Watada, Shiro Tanaka, Jessica Y Matuoka, et al.
Advances in Therapy
|
December 5, 2025
Evaluating the Cost-Effectiveness of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in the Treatment of Patients with Insulin-Treated Type 2 Diabetes in Australia
Hamza Alshannaq, David Simmons, Jessica Y Matuoka, et al.
Journal of Comparative Effectiveness Research
|
September 5, 2023
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada
Hamza Alshannaq, John J Isitt, Richard F Pollock, et al.
Page
of 9